Subscribe on Apple Podcasts, Spotify, Buzzsprout, or follow the podcast on LinkedIn for new episode drops.
In this episode, Carrie, Rebecca, and Zack discuss:
Why Medication Assisted Treatment (MAT) is a proven treatment for Opioid Use Disorder (OUD)
Why only 5% of clinicians are licensed to prescribe buprenorphine and how this drives traffic to the black market
How telemedicine breaks down barriers and stigmas for clinicians and patients in the treatment of OUD, making them an ideal combination for addressing the opioid epidemic in the U
Listen to discover:
What it is like to raise money in femtech from investors that are primarily men
What is it like to build a women’s health company, including tips and tricks for others in this space
How the company’s first emergency contraception product, Relaunch, came to be and the demand, access, and misconceptions around it
What the leaked Roe v. Wade decisions means for the future of women-centric healthcare companies
Why Stix decided early on to take a public stand on this issue and how other femtech founders can, too (even if they don’t know how yet)
In this episode you’ll discover:
How pharmacists can play a critical role in reducing the burden on primary care physicians who are managing the care of chronic disease patients
Why value-based entities are the ideal partners for RxLive
What role drug pricing transparency plays in pharmacists’ ability to help manage high spend on drugs.
